A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker, landiolol hydrochloride, in patients with suspected ischemic cardiac disease

Overview of attention for article published in The International Journal of Cardiovascular Imaging, June 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 7,869 followers.

A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker,... http://t.co/wAIy8C6U2w

Reply Repost Favourite

A randomized, double-blind, placebo-controlled, phase II dose-finding study of the short acting β1-blocker,... http://t.co/O1Tb3M6PzW

Reply Repost Favourite